Page last updated: 2024-10-26

diphenyleneiodonium and Cancer of Prostate

diphenyleneiodonium has been researched along with Cancer of Prostate in 2 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lu, JP1
Monardo, L1
Bryskin, I1
Hou, ZF1
Trachtenberg, J1
Wilson, BC1
Pinthus, JH1
Doroshow, JH1
Gaur, S1
Markel, S1
Lu, J1
van Balgooy, J1
Synold, TW1
Xi, B1
Wu, X1
Juhasz, A1

Other Studies

2 other studies available for diphenyleneiodonium and Cancer of Prostate

ArticleYear
Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase.
    Prostate cancer and prostatic diseases, 2010, Volume: 13, Issue:1

    Topics: Acetophenones; Acetylcysteine; Androgen Antagonists; Androgens; Anilides; Animals; Cell Line, Tumor;

2010
Effects of iodonium-class flavin dehydrogenase inhibitors on growth, reactive oxygen production, cell cycle progression, NADPH oxidase 1 levels, and gene expression in human colon cancer cells and xenografts.
    Free radical biology & medicine, 2013, Volume: 57

    Topics: Animals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclins; Flavoproteins

2013